EDGARDO CONCEPCION: Open Payments
NPI 1326123415 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,873 in 117 payments from 14 companies in 2025. Trend: 2023 $2,489 · 2024 $2,143 · 2025 $2,873
Food & beverage: $2,873
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 16 | $598 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 30 | $417 |
| Otsuka America Pharmaceutical, Inc. | 23 | $404 |
| ABBVIE INC. | 15 | $390 |
| Vanda Pharmaceuticals Inc. | 7 | $251 |
| Axsome Therapeutics, Inc. | 9 | $231 |
| E.R. Squibb & Sons, L.L.C. | 8 | $223 |
| Janssen Scientific Affairs, LLC | 1 | $207 |
| Noven Therapeutics, LLC | 2 | $47 |
| Janssen Pharmaceuticals, Inc | 2 | $26 |
Products named: CAPLYTA, VRAYLAR, REXULTI, ARISTADA, FANAPT, INVEGA SUSTENNA, Auvelity, COBENFY.
Industry payments across LA — which companies pay providers there.
